2026 Global: 3D/4D Ultrasound Equipment Market -Competitive Review (2032) report
Description
The 2026 Global: 3D/4D Ultrasound Equipment Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for 3d/4d ultrasound equipment market by geography and historical trend. The scope of the report extends to sizing of the 3d/4d ultrasound equipment market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
GE HealthCare’s Voluson series leads the 3D/4D ultrasound market with high-resolution fetal and obstetric imaging, integrated HDlive/HDreal rendering modes, extensive women’s-health-specific transducers, and broad global service and upgrade pathways that make it a preferred choice for maternal–fetal medicine centers and elective studios.
Philips offers the EPIQ and Affiniti families that combine nSIGHT beamforming and advanced visualization tools (TrueVue, photorealistic rendering) to deliver exceptional volume rendering and workflow automation for OB/GYN and general imaging practices, backed by strong R&D and clinical partnerships that extend its adoptability in tertiary centers.
Samsung’s Hera and WS80 series emphasize crystal‑clear volume imaging, 5D and HD visualization packages, and ergonomics tailored to busy women’s‑health clinics; the company holds a notable share in women’s-health segments and packages warranty/service bundles that appeal to elective-scan operators.
Mindray provides cost‑competitive 3D/4D capable systems that balance image quality with affordability, offering fetal‑imaging presets, volumetric probes, and modular configurations that suit mid‑size hospitals and private clinics seeking value without sacrificing essential volumetric features.
Canon Medical (formerly Toshiba) integrates high‑definition 3D/4D rendering into systems like the Aplio series, focusing on image consistency, advanced beamforming, and clinical tools for comprehensive fetal assessment that position it well in hospital imaging fleets and specialty OB units.
Siemens Healthineers supplies the ACUSON line with AI‑driven automation, advanced 4D transducer options (including TEE for cardiac 4D) and workflow efficiencies for both fetal and cardiac volumetric imaging, leveraging enterprise partnerships and continual software upgrades for high‑end clinical environments.
FUJIFILM (including Aloka heritage) markets ARIETTA and related platforms with strong volume imaging capabilities, attention to tissue contrast and speckle management, and competitive placements in Asia and emerging markets where robust 3D/4D performance is required at varied price points.
BK Medical (now closely allied with GE in some segments) offers specialized probes and ultrasound platforms optimized for surgical and intraoperative 3D/4D visualization as well as high‑resolution fetal imaging in niche clinical applications where probe flexibility and procedural guidance are critical.
Canon’s competitive presence in workflow‑oriented 3D/4D solutions is matched by several regional specialists such as Alpinion and Chison that deliver targeted volumetric features—lightweight consoles, efficient rendering pipelines, and attractive price/performance for private clinics and regional hospitals seeking 3D/4D capability without flagship pricing.
Emerging and specialty vendors (including Butterfly/handheld entrants for point‑of‑care volumetric approaches and refurbish/reseller networks that supply refurbished Voluson/EPIQ systems) expand market access by offering portable or lower‑cost routes to 3D/4D imaging, fueling adoption in smaller practices, mobile clinics, and elective studios where capital and space constraints are decisive factors.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for 3d/4d ultrasound equipment market by geography and historical trend. The scope of the report extends to sizing of the 3d/4d ultrasound equipment market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
GE HealthCare’s Voluson series leads the 3D/4D ultrasound market with high-resolution fetal and obstetric imaging, integrated HDlive/HDreal rendering modes, extensive women’s-health-specific transducers, and broad global service and upgrade pathways that make it a preferred choice for maternal–fetal medicine centers and elective studios.
Philips offers the EPIQ and Affiniti families that combine nSIGHT beamforming and advanced visualization tools (TrueVue, photorealistic rendering) to deliver exceptional volume rendering and workflow automation for OB/GYN and general imaging practices, backed by strong R&D and clinical partnerships that extend its adoptability in tertiary centers.
Samsung’s Hera and WS80 series emphasize crystal‑clear volume imaging, 5D and HD visualization packages, and ergonomics tailored to busy women’s‑health clinics; the company holds a notable share in women’s-health segments and packages warranty/service bundles that appeal to elective-scan operators.
Mindray provides cost‑competitive 3D/4D capable systems that balance image quality with affordability, offering fetal‑imaging presets, volumetric probes, and modular configurations that suit mid‑size hospitals and private clinics seeking value without sacrificing essential volumetric features.
Canon Medical (formerly Toshiba) integrates high‑definition 3D/4D rendering into systems like the Aplio series, focusing on image consistency, advanced beamforming, and clinical tools for comprehensive fetal assessment that position it well in hospital imaging fleets and specialty OB units.
Siemens Healthineers supplies the ACUSON line with AI‑driven automation, advanced 4D transducer options (including TEE for cardiac 4D) and workflow efficiencies for both fetal and cardiac volumetric imaging, leveraging enterprise partnerships and continual software upgrades for high‑end clinical environments.
FUJIFILM (including Aloka heritage) markets ARIETTA and related platforms with strong volume imaging capabilities, attention to tissue contrast and speckle management, and competitive placements in Asia and emerging markets where robust 3D/4D performance is required at varied price points.
BK Medical (now closely allied with GE in some segments) offers specialized probes and ultrasound platforms optimized for surgical and intraoperative 3D/4D visualization as well as high‑resolution fetal imaging in niche clinical applications where probe flexibility and procedural guidance are critical.
Canon’s competitive presence in workflow‑oriented 3D/4D solutions is matched by several regional specialists such as Alpinion and Chison that deliver targeted volumetric features—lightweight consoles, efficient rendering pipelines, and attractive price/performance for private clinics and regional hospitals seeking 3D/4D capability without flagship pricing.
Emerging and specialty vendors (including Butterfly/handheld entrants for point‑of‑care volumetric approaches and refurbish/reseller networks that supply refurbished Voluson/EPIQ systems) expand market access by offering portable or lower‑cost routes to 3D/4D imaging, fueling adoption in smaller practices, mobile clinics, and elective studios where capital and space constraints are decisive factors.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
